# OPA1

## Overview
OPA1 is a gene that encodes the OPA1 mitochondrial dynamin-like GTPase, a crucial protein involved in mitochondrial dynamics. This protein is categorized as a dynamin-like GTPase and plays a significant role in the fusion of the inner mitochondrial membrane and the maintenance of cristae structure. OPA1 is essential for mitochondrial integrity, influencing processes such as oxidative phosphorylation and apoptosis regulation. The protein exists in multiple isoforms due to alternative splicing and proteolytic processing, which are vital for its diverse functions in mitochondrial morphology and function. Mutations in the OPA1 gene are linked to various clinical conditions, most notably autosomal dominant optic atrophy (ADOA), which is characterized by progressive vision loss. Additionally, OPA1 mutations can lead to a spectrum of disorders with multisystemic manifestations, underscoring its critical role in cellular and mitochondrial health (MacVicar2016OPA1; Del2017OPA1; Lenaers2021Dominant).

## Structure
OPA1 is a mitochondrial dynamin-like GTPase characterized by a complex molecular structure that includes several distinct domains. The protein contains a GTPase domain, a middle domain, and a GTPase effector domain (GED), which are crucial for its function in mitochondrial dynamics (Del2017OPA1). OPA1 also features a mitochondrial targeting sequence (MTS) that directs the protein to the intermembrane space and cristae within mitochondria (Del2017OPA1).

OPA1 is expressed in eight splice variants, resulting from alternative splicing of exons 4, 4b, and 5b, which lead to tissue-specific expression patterns (Del2017OPA1). These variants undergo proteolytic cleavage to produce long (L-OPA1) and short (S-OPA1) forms. The long isoforms are anchored to the inner mitochondrial membrane and are processed by OMA1 and YME1L proteases to generate short isoforms (Del2017OPA1; Lee2017The).

The structural organization of OPA1 is essential for its role in mitochondrial fusion, cristae morphology, and oxidative phosphorylation efficiency. OPA1 oligomerization, regulated by GTP binding and hydrolysis, is important for maintaining mitochondrial network integrity and controlling apoptosis by sequestering cytochrome c within the cristae (Del2017OPA1; Lee2017The).

## Function
OPA1 is a dynamin-like GTPase located in the inner mitochondrial membrane, playing a crucial role in mitochondrial dynamics, particularly in the fusion of the inner mitochondrial membrane (IMM) and cristae morphogenesis. In healthy human cells, OPA1 is essential for maintaining mitochondrial integrity and function by promoting mitochondrial fusion, which is associated with increased respiratory efficiency and the distribution of mitochondrial DNA (MacVicar2016OPA1). OPA1's GTPase activity is critical for maintaining cristae tightness and energetic competency, contributing to oxidative phosphorylation (OXPHOS) function and normal mitochondrial cristae structure (Lee2017The).

OPA1 exists in long (L) and short (S) forms, resulting from proteolytic cleavage. L-OPA1 is necessary for fusion competence, while S-OPA1 can maintain OXPHOS activity and cristae structure (Lee2017The). The balance between L-OPA1 and S-OPA1 is crucial for mitochondrial morphology, with L-OPA1 promoting fusion and S-OPA1 promoting fission (MacVicar2016OPA1). OPA1 also plays a protective role against apoptosis by maintaining cristae ultrastructure, independent of mitochondrial fusion, especially under metabolic stress conditions (MacVicar2016OPA1).

## Clinical Significance
Mutations in the OPA1 gene are primarily associated with autosomal dominant optic atrophy (ADOA), a condition characterized by progressive vision loss due to the degeneration of retinal ganglion cells and their axons (Alexander2000OPA1; Delettre2000Nuclear). ADOA typically presents with bilateral visual impairment, color vision defects, and optic nerve degeneration, often beginning in early childhood (Lenaers2021Dominant). The disease is genetically heterogeneous, with about 70% of cases linked to pathogenic mutations in OPA1 (Lenaers2021Dominant).

In addition to classic ADOA, mutations in OPA1 can lead to a broader spectrum of clinical manifestations known as DOAplus, which include sensorineural hearing loss, ataxia, myopathy, peripheral neuropathy, and progressive external ophthalmoplegia (AmatiBonneau2008OPA1; YuWaiMan2010Multisystem). These multisystemic symptoms are associated with mitochondrial dysfunction and multiple mitochondrial DNA deletions (AmatiBonneau2008OPA1; YuWaiMan2010OPA1).

OPA1 mutations can also result in Behr syndrome, characterized by early-onset optic atrophy and severe neurological symptoms (Lenaers2021Dominant). The clinical severity of OPA1-associated diseases varies significantly, influenced by genetic, epigenetic, and environmental factors (Lenaers2021Dominant).

## Interactions
OPA1, a mitochondrial protein, is involved in several critical interactions with other proteins that regulate mitochondrial dynamics and function. OPA1 interacts with mitofusin proteins, specifically MFN1 and MFN2, which are located in the outer mitochondrial membrane. These interactions are crucial for mitochondrial fusion, with MFN1 being essential for OPA1's fusion activity, while MFN2 is not required (Cipolat2004OPA1). OPA1 also forms oligomers that are important for maintaining cristae junctions, which are vital for preventing apoptosis and cytochrome c release (Frezza2006OPA1).

OPA1 is processed by metalloproteases, including OMA1 and YME1L, which regulate its activity and balance between its long and short isoforms. OMA1 cleaves OPA1 under stress conditions, while YME1L is involved in its regular processing (Gilkerson2021Mitochondrial; Guillery2008Metalloprotease‐mediated). The interaction between OPA1 and PARL, a mitochondrial rhomboid protease, is significant for apoptosis regulation. PARL processes OPA1 to generate a soluble form that is antiapoptotic, highlighting a critical role in cytochrome c release during apoptosis (Cipolat2006Mitochondrial). These interactions underscore OPA1's multifaceted role in maintaining mitochondrial integrity and function.


## References


[1. (Cipolat2004OPA1) Sara Cipolat, Olga Martins de Brito, Barbara Dal Zilio, and Luca Scorrano. Opa1 requires mitofusin 1 to promote mitochondrial fusion. Proceedings of the National Academy of Sciences, 101(45):15927–15932, October 2004. URL: http://dx.doi.org/10.1073/pnas.0407043101, doi:10.1073/pnas.0407043101. This article has 985 citations.](https://doi.org/10.1073/pnas.0407043101)

[2. (Del2017OPA1) Valentina Del Dotto, Prashant Mishra, Sara Vidoni, Mario Fogazza, Alessandra Maresca, Leonardo Caporali, J. Michael McCaffery, Martina Cappelletti, Enrico Baruffini, Guy Lenaers, David Chan, Michela Rugolo, Valerio Carelli, and Claudia Zanna. Opa1 isoforms in the hierarchical organization of mitochondrial functions. Cell Reports, 19(12):2557–2571, June 2017. URL: http://dx.doi.org/10.1016/j.celrep.2017.05.073, doi:10.1016/j.celrep.2017.05.073. This article has 169 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2017.05.073)

[3. (AmatiBonneau2008OPA1) P. Amati-Bonneau, M. L. Valentino, P. Reynier, M. E. Gallardo, B. Bornstein, A. Boissiere, Y. Campos, H. Rivera, J. G. de la Aleja, R. Carroccia, L. Iommarini, P. Labauge, D. Figarella-Branger, P. Marcorelles, A. Furby, K. Beauvais, F. Letournel, R. Liguori, C. La Morgia, P. Montagna, M. Liguori, C. Zanna, M. Rugolo, A. Cossarizza, B. Wissinger, C. Verny, R. Schwarzenbacher, M. A. Martin, J. n Arenas, C. Ayuso, R. Garesse, G. Lenaers, D. Bonneau, and V. Carelli. Opa1 mutations induce mitochondrial dna instability and optic atrophy “plus” phenotypes. Brain, 131(2):338–351, February 2008. URL: http://dx.doi.org/10.1093/brain/awm298, doi:10.1093/brain/awm298. This article has 411 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/brain/awm298)

[4. (YuWaiMan2010Multisystem) P. Yu-Wai-Man, P.G. Griffiths, G.S. Gorman, C.M. Lourenco, A.F. Wright, M. Auer-Grumbach, A. Toscano, O. Musumeci, M.L. Valentino, L. Caporali, C. Lamperti, C.M. Tallaksen, P. Duffey, J. Miller, R.G. Whittaker, M.R. Baker, M.J. Jackson, M.P. Clarke, B. Dhillon, B. Czermin, J.D. Stewart, G. Hudson, P. Reynier, D. Bonneau, W. Marques, G. Lenaers, R. McFarland, R.W. Taylor, D.M. Turnbull, M. Votruba, M. Zeviani, V. Carelli, L.A. Bindoff, R. Horvath, P. Amati-Bonneau, and P.F. Chinnery. Multi-system neurological disease is common in patients with opa1 mutations. Brain, 133(3):771–786, February 2010. URL: http://dx.doi.org/10.1093/brain/awq007, doi:10.1093/brain/awq007. This article has 361 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/brain/awq007)

[5. (YuWaiMan2010OPA1) Patrick Yu-Wai-Man, Kamil S. Sitarz, David C. Samuels, Philip G. Griffiths, Amy K. Reeve, Laurence A. Bindoff, Rita Horvath, and Patrick F. Chinnery. Opa1 mutations cause cytochrome c oxidase deficiency due to loss of wild-type mtdna molecules. Human Molecular Genetics, 19(15):3043–3052, May 2010. URL: http://dx.doi.org/10.1093/hmg/ddq209, doi:10.1093/hmg/ddq209. This article has 89 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddq209)

[6. (Cipolat2006Mitochondrial) Sara Cipolat, Tomasz Rudka, Dieter Hartmann, Veronica Costa, Lutgarde Serneels, Katleen Craessaerts, Kristine Metzger, Christian Frezza, Wim Annaert, Luciano D’Adamio, Carmen Derks, Tim Dejaegere, Luca Pellegrini, Rudi D’Hooge, Luca Scorrano, and Bart De Strooper. Mitochondrial rhomboid parl regulates cytochrome c release during apoptosis via opa1-dependent cristae remodeling. Cell, 126(1):163–175, July 2006. URL: http://dx.doi.org/10.1016/j.cell.2006.06.021, doi:10.1016/j.cell.2006.06.021. This article has 584 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cell.2006.06.021)

[7. (MacVicar2016OPA1) Thomas MacVicar and Thomas Langer. Opa1 processing in cell death and disease – the long and short of it. Journal of Cell Science, 129(12):2297–2306, June 2016. URL: http://dx.doi.org/10.1242/jcs.159186, doi:10.1242/jcs.159186. This article has 280 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.159186)

[8. (Alexander2000OPA1) Christiane Alexander, Marcela Votruba, Ulrike E.A. Pesch, Dawn L. Thiselton, Simone Mayer, Anthony Moore, Miguel Rodriguez, Ulrich Kellner, Beate Leo-Kottler, Georg Auburger, Shomi S. Bhattacharya, and Bernd Wissinger. Opa1, encoding a dynamin-related gtpase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nature Genetics, 26(2):211–215, October 2000. URL: http://dx.doi.org/10.1038/79944, doi:10.1038/79944. This article has 1032 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/79944)

[9. (Delettre2000Nuclear) Cécile Delettre, Guy Lenaers, Jean-Michel Griffoin, Nadine Gigarel, Corinne Lorenzo, Pascale Belenguer, Laetitia Pelloquin, Josiane Grosgeorge, Claude Turc-Carel, Eric Perret, Catherine Astarie-Dequeker, Laetitia Lasquellec, Bernard Arnaud, Bernard Ducommun, Josseline Kaplan, and Christian P. Hamel. Nuclear gene opa1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nature Genetics, 26(2):207–210, October 2000. URL: http://dx.doi.org/10.1038/79936, doi:10.1038/79936. This article has 1118 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/79936)

[10. (Gilkerson2021Mitochondrial) Robert Gilkerson, Patrick De La Torre, and Shaynah St. Vallier. Mitochondrial oma1 and opa1 as gatekeepers of organellar structure/function and cellular stress response. Frontiers in Cell and Developmental Biology, March 2021. URL: http://dx.doi.org/10.3389/fcell.2021.626117, doi:10.3389/fcell.2021.626117. This article has 66 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2021.626117)

[11. (Lenaers2021Dominant) Guy Lenaers, Albert Neutzner, Yannick Le Dantec, Christoph Jüschke, Ting Xiao, Sarah Decembrini, Sebastian Swirski, Sinja Kieninger, Cavit Agca, Ungsoo S. Kim, Pascal Reynier, Patrick Yu-Wai-Man, John Neidhardt, and Bernd Wissinger. Dominant optic atrophy: culprit mitochondria in the optic nerve. Progress in Retinal and Eye Research, 83:100935, July 2021. URL: http://dx.doi.org/10.1016/j.preteyeres.2020.100935, doi:10.1016/j.preteyeres.2020.100935. This article has 58 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.preteyeres.2020.100935)

[12. (Frezza2006OPA1) Christian Frezza, Sara Cipolat, Olga Martins de Brito, Massimo Micaroni, Galina V. Beznoussenko, Tomasz Rudka, Davide Bartoli, Roman S. Polishuck, Nika N. Danial, Bart De Strooper, and Luca Scorrano. Opa1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell, 126(1):177–189, July 2006. URL: http://dx.doi.org/10.1016/j.cell.2006.06.025, doi:10.1016/j.cell.2006.06.025. This article has 1317 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cell.2006.06.025)

[13. (Guillery2008Metalloprotease‐mediated) Olwenn Guillery, Florence Malka, Thomas Landes, Emmanuelle Guillou, Craig Blackstone, Anne Lombès, Pascale Belenguer, Damien Arnoult, and Manuel Rojo. Metalloprotease‐mediated opa1 processing is modulated by the mitochondrial membrane potential. Biology of the Cell, 100(5):315–325, May 2008. URL: http://dx.doi.org/10.1042/bc20070110, doi:10.1042/bc20070110. This article has 130 citations and is from a peer-reviewed journal.](https://doi.org/10.1042/bc20070110)

[14. (Lee2017The) Hakjoo Lee, Sylvia B. Smith, and Yisang Yoon. The short variant of the mitochondrial dynamin opa1 maintains mitochondrial energetics and cristae structure. Journal of Biological Chemistry, 292(17):7115–7130, April 2017. URL: http://dx.doi.org/10.1074/jbc.m116.762567, doi:10.1074/jbc.m116.762567. This article has 139 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m116.762567)